ESC & iPSC News 12.02 January 18, 2017 | |
| |
TOP STORYDeficiency of MicroRNA miR-34a Expands Cell Fate Potential in Pluripotent Stem Cells Researchers showed that microRNA miR-34a deficiency expands the developmental potential of mouse pluripotent stem cells to yield both embryonic and extra-embryonic lineages and strongly induce MuERV-L endogenous retroviruses, similar to what is seen with totipotent 2-cell blastomeres. [Science] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators generated induced pluripotent stem cells (iPSCs) from acute myeloid leukemia (AML) patient samples harboring MLL rearrangements and found that they retained leukemic mutations but reset leukemic DNA methylation/gene expression patterns. [Cell Stem Cell] Abstract | Graphical Abstract Investigating 1-ethyl-2-benzimidazolinone (EBIO) in human pluripotent stem cells, the authors applied three independent differentiation protocols of low to high cardiomyogenic efficiency. Their study revealed extensive EBIO-triggered cell loss favoring cardiac progenitor preservation and, subsequently, cardiomyocytes with shortened action potentials. [Stem Cell Reports] Full Article | Graphical Abstract Researchers demonstrated that cultured mouse embryonic stem cells express platelet-derived growth factor receptor alpha (PDGFRα) heterogeneously, fluctuating between a PDGFRα+ and a platelet endothelial cell adhesion molecule 1 positive state. [Stem Cell Reports] Full Article | Graphical Abstract Jmjd2/Kdm4 H3K9-demethylases cooperate in promoting mouse embryonic stem cell (ESC) identity. However, little is known about their importance at the exit of ESC pluripotency. The authors uncovered that Jmjd2c facilitates this process by stabilizing the assembly of mediator-cohesin complexes at lineage-specific enhancers. They show that Jmjd2c is required in ESCs to initiate appropriate gene expression programs upon somatic multi-lineage differentiation. [Development] Abstract | Full Article Scientists established two isogenic induced pluripotent stem cell (iPSC) lines each carrying different proportions of a heteroplasmic m.3243A>G mutation from the same patient; one exhibited apparently normal and the other showed most likely impaired mitochondrial respiratory function. [Cell Death Dis] Full Article Researchers tested whether acellular mammary extracellular matrix preparations are sufficient to direct differentiation of testicular-derived cells and embryonic stem cells to form functional mammary epithelial trees in vivo. [Sci Rep] Full Article The authors identified Icaritin, a phytoestrogen molecule enhances self-renewal of mouse embryonic stem cells (mESCs). Icaritin increases mESCs proliferation while maintains their self-renewal capacity in vitro and pluripotency in vivo. [Sci Rep] Full Article Investigators described a label-free separation of induced pluripotent stem cells using a microfluidic channel. Antibodies against stage-specific embryonic antigen 1 (SSEA-1) were covalently immobilized on the channel coated with a phospholipid polymer. [Langmuir] Abstract The authors showed that Activin A has an ability to efficiently propagate embryonic stem cells without differentiation to epiblast stem cells when combined with a MEK inhibitor PD0325901. [Genes Cells] Abstract A Xenogeneic-Free System Generating Functional Human Gut Organoids from Pluripotent Stem Cells Scientists developed a simple protocol for the generation of mature functional intestinal organoids from human pluripotent stem cells under xenogeneic-free conditions. [JCI Insight] Full Article | Press Release | |
| |
REVIEWSStem Cell Therapy: An Emerging Modality in Glomerular Diseases The authors focus on stem cell therapy approaches for the treatment of glomerular disease, including the various cell sources used and recent advances in preclinical and clinical studies. [Cytotherapy] Abstract Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSSupport for Chicago Biomedical Consortium Renewed The Searle Funds at The Chicago Community Trust has renewed its funding commitment to the Chicago Biomedical Consortium, an innovative research and education collaboration of Northwestern University, the University of Illinois at Chicago and the University of Chicago that has helped establish the Chicago area as a leader in biomedical sciences. [Northwestern University] Press Release Asterias Announces Conference Call to Discuss Six-Month Efficacy Data from AST-OPC1 SCiStar Study Asterias Biotherapeutics, Inc. announced that the company will host a conference call on Tuesday, January 24, 2017 to discuss new data evaluating the efficacy results six months after implantation of 10 million AST-OPC1 cells in patients with complete cervical spinal cord injuries in the ongoing SCiStar study. [Asterias Biotherapeutics, Inc.] Press Release | |
| |
POLICY NEWSU.S. Abandons Controversial Consent Proposal on Using Human Research Samples Federal officials have dropped a controversial plan to impose new rules that researchers say would have made it much harder to use patient blood and tissue samples in research. The final Common Rule omits these provisions, but leaves other changes intact. [ScienceInsider] Editorial Rigorous Replication Effort Succeeds for Just Two of Five Cancer Papers The first results of a high-profile effort to replicate influential papers in cancer biology are roiling the biomedical community. Of the five studies the project has tackled so far, some involving experimental treatments already in clinical trials, only two could be repeated; one could not, and technical problems stymied the remaining two replication efforts. [ScienceInsider] Editorial Croatia’s Science Minister Rejects Calls to Resign amid Plagiarism Scandal In a plagiarism scandal in Croatia, the country’s highest-level research ethics committee is clashing with its science minister — who says he won’t step down after the committee found he had copied another scholar’s work. Scientists say the case raises questions about academic integrity at the top of a research system that is already riven with misconduct allegations. [Nature News] Editorial
| |
EVENTSNEW Gordon Research Conference – Germinal Stem Cell Biology Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Multiple Areas (University of Oklahoma) NEW Regulatory Support Scientist – Biological Product Development (Cook MyoSite, Inc.) NEW Regulatory Affairs Scientist – Scientific Evaluation and Writing (Cook MyoSite, Inc.) Postdoctoral Fellow – Development of the Cardiovascular System (Goethe University Frankfurt) Postdoctoral Fellow – Human Embryology and Stem Cell Biology (The Francis Crick Institute) Research Scientist – Stem Cell Gene Editing (Universal Cells Inc.) Assistant Professor – Heart Tissue Regeneration (University of Cincinnati) Tenure Track Faculty – Stem Cells and Regenerative Medicine (University of Notre Dame) Postdoctoral Fellowship – 3D Genome Organizers in Development and Disease (Karolinska Institute) Assistant or Associate Member – Stem CellGene Therapy (Fred Hutchinson Cancer Research Center) Postdoctoral Fellow – Pluripotent Stem Cell Technology (University of California, Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home ESC & iPSC News Volume 12.02 | Jan 18 2017